PAK4 phosphorylates fumarase and blocks TGF-β-induced cell growth arrest in lung cancer cells.
By: Yuhui Jiang, Tao Chen, Ting Wang, Wenhua Liang, Qin Zhao, Qiujing Yu, Chun-Min Ma, Lingang Zhuo, Dong Guo, Ke Zheng, Chengzhi Zhou, Shupei Wei, Wenhua Huang, Juhong Jiang, Jing Liu, Shiyue Li, Jianxing He, Nanshan Zhong

Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, The Institute of Cell Metabolism and Disease, Shanghai Key Laboratory of Pancreatic Cancer yhjiang@shsmu.edu.cn.
2019-01-23; doi: 10.1158/0008-5472.CAN-18-2575
Abstract

The metabolic activity of fumarase (FH) participates in gene transcription linking to tumor cell growth. However, whether this effect is implicated in lung cancer remains unclear. Here, we show TGF-β induces p38-mediated FH phosphorylation at Thr 90, which leads to a FH/CSL (also known as RBP-Jκ) /p53 complex formation and FH accumulation at p21 promoter under concomitant activation of Notch signaling; in turn, FH inhibits histone H3 Lys 36 demethylation and thereby promotes p21 transcription and cell growth arrest. In addition, FH is massively phosphorylated at the Ser 46 by PAK4 in NSCLC cells; and PAK4-phosphorylated FH binds to 14-3-3, resulting in cytosolic detention of FH and prohibition of FH/CSL/p53 complex formation. Physiologically,FH Ser 46 phosphorylation promotes tumorigenesis through its suppressive effect on FH Thr 90 phosphorylation-mediated cell growth arrest in non-small cell lung cancer (NSCLC) cells and correlates with poor prognosis in lung cancer patients. Our findings uncover an uncharacterized mechanism underlying the local effect of FH on TGF-β induced-gene transcription, on which the inhibitory effect from PAK4 promotes tumorigenesis in lung cancer.



Copyright ©2019, American Association for Cancer Research.

PMID:30683654






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements